Next-generation rheumatoid factor assay provides improved predictive power for the development of arthritis in patients at risk
Objective Rheumatoid arthritis (RA) is characterised by the presence of autoantibodies, among which those targeting the constant region of immunoglobulin G (IgG), called rheumatoid factors (RF). Despite this link, RFs can also be found in other disorders and the healthy population, which hampers its...
Saved in:
| Main Authors: | Gertjan Wolbink, Theo Rispens, Dirkjan van Schaardenburg, Laurette van Boheemen, Pleuni Ooijevaar-De Heer, Nienke Oskam, Dorien Kos |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-09-01
|
| Series: | RMD Open |
| Online Access: | https://rmdopen.bmj.com/content/10/3/e004172.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Different rheumatoid factor binding patterns distinguish between Sjögren’s disease with or without associated RA
by: Hendrika Bootsma, et al.
Published: (2025-06-01) -
The TNFα-binding domain of the therapeutic antibody adalimumab elicits CD4 T-cell responses in rheumatoid arthritis patients
by: Mateusz Makuch, et al.
Published: (2025-07-01) -
Long-term effectiveness of a lifestyle intervention for rheumatoid arthritis and osteoarthritis: 1-year follow-up of the ‘Plants for Joints’ randomised clinical trial
by: Jos W R Twisk, et al.
Published: (2024-02-01) -
Probiotic-derived extracellular vesicles: the next breakthrough in postbiotics for rheumatoid arthritis
by: Federica Dell’Atti, et al.
Published: (2025-08-01) -
Pharmacokinetic Model‐Informed Precision Dosing of Natalizumab in Multiple Sclerosis
by: Stefan P. H. van denBerg, et al.
Published: (2025-06-01)